Exendins and exendin agonist analogs to regulate gastrointestinal motility

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8026210
APP PUB NO 20090163423A1
SERIAL NO

12353861

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist. Methods for treating conditions associated with elevated, inappropriate, or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist alone or in conjunction with other anti-gastric emptying agents.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMYLIN PHARMACEUTICALS INC9360 TOWNE CENTRE DRIVE SAN DIEGO CA 92121

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gedulin, Bronislava Del Mar, US 50 1752
Young, Andrew A Rancho Santa Fe, US 80 3117

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation